Juniper Genomics Debuts Whole-Genome and Transcriptome Test
Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.
Juniper Genomics has launched publicly to offer a next-generation embryo screening platform that aims to improve IVF outcomes.
New research reveals that the saliva of pregnant women shows differences in their oral microbiome based on their levels of life stress.
A specific genetic variant found in about 7% of Dutch women reduces the accuracy of NIPT, increasing the likelihood of inconclusive results.
Menarini Silicon Biosystems presented a study, about its advanced non-invasive prenatal testing technology using maternal blood.
Read MoreMeasuring blood levels of homocysteine can help predict the risk and progression of obstructive sleep apnea.
Read MoreRecent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read MoreThe test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read MoreLabs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read MoreLabcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read MorePinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.Â
Read MoreResearchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read MoreClinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read MoreAgilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MoreThe AMH Assay can support a lab’s reproductive endocrinology test menu as it aids a physician’s assessment of initiating IVF with a patient.
Read MoreThe test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.Â
Read MoreA new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read MoreCLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read MoreFort Worth Diagnostics utilizes digital PCR to establish the assays and ensure reproducibility while manufacturing high-quality materials.
Read More